Talecris Biotherapeutics Holdings Corp.Research Triangle Park, NC, United States (NASDAQ (GM): TLCR Proposed)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

Talecris Income Statement

All amounts in millions of except per share amounts.
View: Annual
Dec 06 Dec 05 Dec 04
Revenue 1,114.5 913.5 846.5
Cost of Goods Sold 684.8 770.8 661.5
Gross Profit 429.7 142.7 185.0
Gross Profit Margin 38.6% 15.6% 21.9%
SG&A Expense 308.2 168.7 161.2
Depreciation & Amortization -- -- --
Operating Income 135.7 (26.0) 23.8
Operating Margin 12.2% -- 2.8%
Nonoperating Income 0.7 0.2 0.0
Nonoperating Expenses 49.8 21.2 0.0
Income Before Taxes 86.6 (47.0) 23.8
Income Taxes 2.2 7.4 18.5
Net Income After Taxes 84.4 (54.4) 5.3

Continuing Operations 84.4 (54.4) 5.3
Discontinued Operations 0.0 0.0 0.0
Total Operations 84.4 (54.4) 5.3
Total Net Income 87.4 222.7 5.3
Net Profit Margin 7.8% 24.4% 0.6%

Diluted EPS from Total Net Income ($) -- -- --
Dividends per Share -- -- --